Label-free blood serum detection by using surface-enhanced Raman spectroscopy and support vector machine for the preoperative diagnosis of parotid gland tumors by Bing Yan et al.
RESEARCH ARTICLE Open Access
Label-free blood serum detection by using
surface-enhanced Raman spectroscopy and
support vector machine for the preoperative
diagnosis of parotid gland tumors
Bing Yan1, Bo Li2, Zhining Wen3, Xianyang Luo1, Lili Xue4 and Longjiang Li2*
Abstract
Background: It is difficult for the parotid gland neoplasms to make an accurate preoperative diagnosis due to the
restriction of biopsy in the parotid gland neoplasms. The aim of this study is to apply the surface-enhanced Raman
spectroscopy (SERS) method for the blood serum biochemical detection and use the support vector machine for
the analysis in order to develop a simple but accurate blood serum detection for preoperative diagnosis of the
parotid gland neoplasms.
Methods: The blood serums were collected from four groups: the patients with pleomorphic adenoma, the
patients with Warthin’s tumor, the patients with mucoepidermoid carcinoma and the volunteers without parotid
gland neoplasms. Au nanoparticles (Au NPs) were mixed with the blood serum as the SERS active nanosensor to
enhance the Raman scattering signals produced by the various biochemical materials and high quality SERS
spectrum were obtained by using the Raman microscope system. Then the support vector machine was utilized to
analyze the differences of the SERS spectrum from the blood serum of different groups and established a
diagnostic model to discriminate the different groups.
Results: It was demonstrated that there were different intensities of SERS peaks assigned to various biochemical
changes in the blood serum between the parotid gland tumor groups and normal control group. Compared with
the SERS spectra of the normal serums, the intensities of peaks assigned to nucleic acids and proteins increased in
the SERS spectra of the parotid gland tumor serums, which manifested the differences of the biochemical
metabolites in the serum from the patients with parotid gland tumors. When the leave-one-sample-out method
was used, support vector machine (SVM) played an outstanding performance in the classification of the SERS
spectra with the high accuracy (84.1 % ~ 88.3 %), sensitivity (82.2 % ~ 97.4 %) and specificity (73.7 % ~ 86.7 %).
Though the accuracy, sensitivity and specificity decreased in the leave-one-patient-out cross validation, the
mucoepidermoid carcinoma was still easier to diagnose than other tumors.
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Discussion: The specific molecular differences of parotid gland tumors and normal serums were significantly
demonstrated through the comparison between the various SERS spectra.But compared with the serum SERS
spectra reported in the other studies, some differences exist between the spectra in this study and the ones
reported in the lietratures. These differences may result from the various nano-particles, the different preparation of
serum and equipment parameters, and we could need a further research to find an exact explanation.Based on the
SERS spectra of the serum samples, SVM have shown a giant potential to diagnose the parotid gland tumors in our
preliminary study. However, different cross validaiton methods could effect the accuracy and a further study
involing a great number of samples should be needed.
Conclusions: This exploratory research demonstrated the great potential of SERS combined with SVM into a
non-invasive clinical diagnostic method for preoperative diagnosis of parotid gland tumors. And the internal
relation between the spectra and patients should be established in the further study.
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Background
Among the neoplasms arising in the salivary glands,
the parotid gland tumors are the most common with a
frequency about 80 % [1, 2]. The accurate preoperative
diagnosis of the parotid gland tumors is very essential
and important clinically, because the discrimination be-
tween the benign and malignant tumors influences the
following management of the optimal surgical proce-
dures [2, 3]. Unfortunately, the routine biopsy is not
recommended in the parotid gland tumors due to the
possibility of the implantation metastasis and facial nerve
injury [2]. Although the fine needle aspiration biopsy is
considered as a well-established diagnostic technique in
the preoperative diagnosis of parotid gland tumors, it can
still lead to some defects and limits such as hematoma
and bacterial infection. Meanwhile, the result of fine
needle aspiration biopsy could be influenced by the ex-
periences of the operator and pathologist [2, 4–6]. So it
is important and essential to develop a new technique
to make an accurate and noninvasive preoperative diag-
nosis of parotid gland tumors.
Raman spectroscopy is a vibrational spectroscopic tech-
nique based on the inelastic scattering, which can reflect
the molecular structures and changes of samples and
considered as the molecular ‘fingerprint’ [7–9]. Due to
the technical advances in the Raman spectroscopy system
instruments and application of multivariate analytic al-
gorithm, the potential use of Raman spectroscopy has
been widely developed in tumor diagnostics [2, 10, 11].
Compared with other optical diagnostic technique, Raman
spectroscopy owns the advantages such as non-invasive,
high spatial resolution, weak water scattering and no sam-
ple preparation [10, 12, 13]. However, the signal of Raman
spectrum produced by a smaller number of photons (ap-
proximately 1 in 106 to 1 in 108) is very weak and covered
by a strong autofluorescence background in some cases
[14]. These drawbacks hindered the further clinical
application in tumor diagnosis. In order to overcome these
drawbacks, the increased excitation laser power and
collection time were used, but these resulted in the
changes and damages of biochemical samples. So the
surface-enhanced Raman spectroscopy (SERS) is developed
and becomes a promising solution. The SERS is based on
the effect of surface-enhanced Raman scattering that
the signal of Raman scattering can be greatly enhanced
by 105–1014 when the molecules are absorbed onto
nanostructured metal or colloid surfaces [16–18]. Be-
cause of the increased Raman scattering cross-section
and high sensitivity, SERS can overcome the drawback
of regular Raman spectroscopy and is applied success-
fully in the diagnosis and discrimination of various tu-
mors [16, 18, 19].
The successful use of Raman spectroscopy in the ex
vivo diagnosis of the parotid gland tumors has been
reported in our previous studies [2, 20]. Due to the
interference of the superficial skin and subcutaneous
tissues, the Raman spectroscopy of parotid gland tumors
cannot be obtained successfully in our in vivo study. Previ-
ous studies have shown that the plasma or serum levels of
RNA, DNA and other biochemical materials changed in pa-
tients with cancer and the SERS of peripheral blood, plasma
Table 1 Information on these subjects in this study
Information Group
PA WT MEC Normal
Age (year)
Age range 28–68 35–74 29–79 18–65
Median age 41 59 43 35
Gender
Male 8 17 10 20
Female 12 4 9 11
Total 20 21 19 31
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or serum could be used to detect the presence of cancer
with a high sensitivity and specificity [16, 18, 21, 22]. So the
SERS of peripheral blood could provide an opportunity for
non-invasive preoperative diagnosis of parotid gland tu-
mors. In this study, we firstly developed the method of
blood serum detection by using SERS based on label-free
Au nanoparticles to diagnose the parotid gland tumors
preoperatively. The support machine vector is applied
to analyze the differences between the SERS data and
discriminate the patients from healthy subjects.
Methods
Subjects and protocol
In this study, all the patients with the parotid gland tumors
were divided into the pleomorphic adenoma (PA) group,
the Wartin’s tumor (WT) group and mucoepidermoid car-
cinoma (MEC) group. Then the patients with old
maxillofacial fracture and healthy volunteers were se-
lected as the normal control group. The more de-
tailed information on the subjects was shown in
Table 1. All the subjects in this study were not
treated prior to this study, didn’t have any other sys-
temic diseases or drug abuse, and their blood routine
and biochemistry examinations were all in the normal
range. The final diagnoses of patients with the parotid
gland tumors were carried out by two experienced
pathologists after the surgical operation according to
the World Health Organization histological criteria
[23]. All the subjects participated in this study were
informed detailedly and gave their written informed
consent at the beginning of the study. This study was
approved by the Institution Review Board of West
China Hospital of Stomatology and followed the
guidelines of the Helsinki Declaration.
Fig. 1 a The UV/visible absorption spectra of the Au NPs, serum and the mixture of Au NPs and serum. b SERS spectrum of serum, normal
Raman spectrum of serum and background Raman spectrum of the Au NPs colloid. c The SEM images of Au NPs. d The SEM images of the
mixture of Au NPs and serum
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Blood serum samples
After 10 h of overnight fasting, a single 5 ml periph-
eral blood sample was obtained from the subjects at
8:00 A.M. without any anticoagulant. Then the blood
sample was deposited at 4 °C for 4 h and centrifuged
at 3400 rpm (2722 g) for 10mins in order to remove
the blood cells, fibrinogen and platelet. After the cen-
trifugation, the blood serum was obtained and 1 ml
supernatant was collected as the serum sample and
stored at −20 °C for Raman measurement.
Preparation of Au NPs
Au NPs were prepared through the deoxidizing process
according to the method reported by Frens [24]. A beaker
of 100 ml of 0.1 g/L HAuCl4 was heated to the rolling boil
and then added the 0.7 ml of 10 g/L sodium citrate rap-
idly. The mixed solution was heated to keep boiling and
stirred continuously for 30mins. During this process, the
color of the solution changed from pale yellow to bur-
gundy due to the production of Au NPs. The nanoparticle
form of the Au NPs prepared in the above method was
spherical with a mean diameter of 55 nm and the UV-
visible absorption spectrum shown a significant absorption
at 550 nm (Fig. 1).
SERS measurement
A 4 ml Au NPs solution was centrifuged at 6000 rpm
(3219 g) for 10mins,discarded the supernatant and added a
0.4 ml serum sample for the SERS measurement. Before
the SERS measurement, the mixed solution was incubated
at 4 °C for 2 h. Then a drop of the mixed solution was
transferred onto the coverslip for the SERS detection.
The confocal Raman micro-spectrometer system
(Renishaw, Great Britain) was employed for the SERS
measurement of the serum sample using a 633 nm exci-
tation laser. The excitation laser with a power of ap-
proximately 0.4 W was focused on 4–6 regions of each
drop for the SERS spectral record through a × 50 ob-
jective lens (NA = 0.75). The spectra were recorded in
the 200–1800 cm–1 Raman shift range with a 2 cm−1
spectral resolution and a 10s integration time.
Data analysis
The raw spectral data were preprocessed by WiRE 2.0
software (Renishaw, Great Britain) before the Data stat-
istical analysis in order to remove the interference noises
and oversaturated spectra. The LABSPEC 2.0 software
(HORIBA Scientific, France) was utilized to remove the
autofluorescence background by the 4th polynomial
function and smooth the SERS spectra by the Savitzky-
Golay smoothing. And all the smoothed SERS spectra
were normalized in the region of 200–1800 cm−1.
Then the preprocessed data were put into the Origi-
nPro8.0 software(OringinLab, USA) to calculate and
produce the mean spectrum of each group. The com-
parison between the spectra of parotid gland tumors
group and normal group were made through the subtrac-
tion of different mean spectra and the shifts of the differ-
ent peaks in the subtracted spectral were assigned to the
molecular structures and biochemical component based
on the previous studies and literatures [15–18, 25–31]
(Table 2).
In the process of training SVM, the Gaussian radial
basis function was selected and the Jackknife method
was employed to optimize the penalty parameter C and
kernel-related parameter gamma [20]. Then in the
process of testing SVM, the leave-one-sample-out and
leave-one-patient- out methods were utilized to test the
prediction performance of the diagnostic model estab-
lished in the process of training SVM. And when the
leave-one-patient-out method was applied, all spectra
from one patient were left out to test the prediction.
Due to the classification of tumor and normal samples,
the process of discrimination and diagnosis was divided
into two steps as reported in the previous literature [20].
First, the SVM was employed to discriminate the tumor
groups from the normal group. Then, the tumor group
were classified and diagnosed by SVM respectively. In
order to value the efficiency of the model developed by
SVM, the employed parameters were as following: the
specificity (SP), sensitivity (SE), accuracy (ACC), Mat-
thew correlation coefficient (MCC) and rigidity (R).
Table 2 Raman shifts of peaks and the characteristic
assignments [15–18, 25–31]
Raman shift (cm−1) Peak assignment
292–296 Au-S band
543–548 S-S disulfide stretching in Proteins
723–727 Hypoxanthine
744–747 Thymine in DNA
933 C-C stretching mode, C-C αhelix in proteins
1084 C-C stretching mode in phospholipids
1094 C-N stretching mode in D-Mannos
1127 C-C stretching in lipids, C-N stretching in D-Mannos
1140 Carotenoids
1261–1264 CH bending in lipids
1326–1329 CH vibration in DNA/RNA, CH2 twisting in lipids
1368–1373 Guanine in DNA, Tryptophan in proteins
1441–1445 CH2, CH3 bending in proteins and lipids
1541–1551 C-N stretching, Amide II
1607 C = C band in Phenylalanine or Tyrosine
1698–1699 Amide I
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Fig. 2 The average Raman spectra of PA, WT, MEC and normal control samples. (a: The average spectrum of PA. b: The average spectrum of WT.
c: The average spectrum of MEC. d: The average spectrum of normal samples). The gray areas manifest the standard deviations
Fig. 3 a Comparison of the PA and normal group. b Comparison of the WT and normal group. c Comparison of the MEC and normal group
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Result
SERS spectra
In the UV-visible absorption spectra shown as Fig. 1a,
the pure serum samples absorption band appeared in
the around 420 nm wavelength region and the band of
Au NPs appeared in the around 550 nm wavelength re-
gion. When the Au NPs were mixed with the serum, the
intense of their assigned absorption bands reduced and
the shapes of peaks changed. This result was believed to
originate from the localized surface plasmon resonance
of Au NPs deposited on the biochemical substances in
serum [15, 28]. Compared with the normal Raman
spectrum, there was a dramatic increase in the intensity
of serum SERS, which was resulted from the surface
enhance effect produced by Au NPs [Fig. 1b]. The SEM
images of the pure Au NPs and the mixture of Au NPs
and serum were shown in the Fig. 1c and d respectively.
The SEM image showed the conjunction of Au NPs
and biochemical substances in serum.
After the SERS measurement, a total of 454 SERS
spectra were obtained successfully from the 91 serum
samples, including 101 spectra of PA samples, 105 spec-
tra of WT samples, 95 spectra of MEC samples and 153
spectra of normal samples. The mean SERS spectra of
different samples before the spectral normalization were
shown in the Fig. 2. Then compared with the normalized
mean SERS spectra of the normal groups, the PA groups
showed the increase in the peaks at 548, 724, 747, 933,
1094, 1328, 1371, 1445, 1698 cm−1 but the decrease in
the peaks at 295, 1551, 1607 cm−1, which was shown in
the subtracted spectrum in Fig. 3a. There were also dif-
ferences in the mean SERS spectra between the normal
groups and the WT groups, the subtracted spectra in
Fig. 3b showed the increase in the peaks at 296, 450,
543, 727, 744, 1084, 1140, 1264, 1326, 1373, 1444 and
1699 cm−1 but the only decrease in the peak at 1548 cm−1.
The subtracted spectrum from the MEC and normal
groups showed the increase in the peaks at 548, 723, 934,
1127, 1329, 1368 and 1441 cm−1 but the decrease in the
peaks at 292, 1261, 1541 and 1607 cm−1, which was shown
in the Fig. 3c. All these peaks can be assigned to different
biochemical components and molecular structures such
as nucleic acids and proteins, and in order to better
understand the different peaks in the subtracted spectra,
Table. 2 lists the characteristic assignments of peaks at dif-
ferent Raman shifts based on the previous literatures and
studies. In the parotid tumors groups, compared with the
normal groups, the intensities of peaks at the 720–750 cm
−1 and 900–1450 cm−1 regions increased, which were
assigned to the molecular structures in the nucleic acids,
proteins and lipids, but the intensities of peaks at the
around 1500–1600 cm−1 region decreased, which were
assigned to some special molecular bond or vibration. The
assignments of major peaks can be shown in Table 2. And
based on these differences of peaks, the spectra of differ-
ent tumors and normal groups can be classified and
diagnosed.
SVM diagnosis
In order to develop effective diagnostic algorithms for
differentiation between the parotid tumor groups and
normal group, the process of SVM diagnosis contains
two steps. The first step was to discriminate the normal
samples from the parotid tumor samples respectively, in
which the normal samples were selected as the positive
group and the parotid tumors as the negative group. As
the result of the leave-one-sample-out method, 78 of
101 PA spectra, 78 of 105 WT spectra and 91 of 95
MEC spectra were classified correctly in the first step.
According to the above results, the SVM could diagnoses
the different spectra from the parotid tumors and normal
samples successfully, and the parameters SP, SE, ACC,
MCC and R of the SVM diagnostic results were shown in
the Table 3. Then the diagnosis of different parotid tumor
samples was also carried out by using SVM in the second
Table 3 The parameters of the ‘Leave-one-sample’ classification
results of the spectra from parotid tumor samples and normal
samples using SVM
Parameter Normal vs PA Normal vs WT Normal vs MEC
SP 77.2 % 74.3 % 73.7 %
SE 93.5 % 90.8 % 97.4 %
ACC 87.5 % 84.1 % 88.3 %
MCC 0.727 0.668 0.755
R 0.780 0.737 0.765
Table 4 The parameters of the ‘Leave-one-sample’ classification
results of the spectra from the different parotid tumor samples
using SVM
Parameter PA vs WT PA vs MEC WT vs MEC
SP 86.7 % 82.1 % 86.3 %
SE 82.2 % 90.1 % 84.8 %
ACC 84.5 % 86.2 % 85.5 %
MCC 0.689 0.725 0.710
R 0.832 0.812 0.836
Table 5 The parameters of the ‘Leave-one-patient’ classification
results of the spectra from parotid tumor samples and normal
samples using SVM
Parameter Normal vs PA Normal vs WT Normal vs MEC
SP 79.1 % 79.1 % 93.5 %
SE 57.4 % 51.4 % 64.2 %
ACC 70.5 % 67.8 % 82.3 %
MCC 0.371 0.328 0.621
R 0.663 0.639 0.862
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step. The results showed that SVM achieved an acceptable
performance on the classification of different parotid
gland tumors. And the parameters SP, SE, ACC, MCC and
R in the second step were shown in Table 4. And when
the leave-one-patient-out method was applied, 58 of 101
PA spectra, 54 of 105 WT spectra and 61 of 95 MEC
spectra were classified correctly in the first step. And the
results of the classification by this method were shown in
Tables 5 and 6.
Discussion
In clinical examination, the blood samples are easily
collected and mostly reflect some vital subtle change
caused by tumors in the metabolism environment, such
as amino acid metabolism, miRNA expression and bio-
markers generation [32–34]. The concentration of nucleic
acids and the composition of proteins from the serum and
plasma samples of tumor patients are different from the
normal samples, which are believed to originated from
apoptosis, tumor necrosis and associated metabolites [22].
So in our exploratory study, blood serum detection is ap-
propriate for the preoperative diagnosis of parotid gland
tumors. It would be a revolution of tumor screening by
using SERS to detect periphery blood samples for the
preoperative diagnosis of parotid gland tumors.
In our study, the specific molecular differences of par-
otid gland tumors and normal serums were significantly
demonstrated through the comparison between the vari-
ous SERS spectra. These differences or alterations would
be related with the proliferation and metabolism of tu-
mors. In the comparison between the tumors and normal
serums, the SERS peaks at around 723–727 cm−1 and
744–747 cm−1 assigned to the hypoxanthine and thymine
in nucleic acids manifested the higher intensity in the par-
otid gland tumor groups, which could be resulted from
the active metabolism of nucleic acids in the patients with
parotid gland tumors. This result is also in agreement with
the studies on the Raman spectra of parotid gland tumor
tissues [2, 20]. The SERS peak at around 1326–1329 cm−1
was assigned to the CH vibration structure in nucleic
acids, and the increased intensity of this peak in parotid
gland tumor groups also suggested that there was an in-
creased amount of nucleic acids in the serums from the
patients with parotid gland tumors. This difference can be
explained by the increased cell-free nucleic acids which
originated from the apoptosis, necrosis and release of in-
tact cells in the bloodstream and their subsequent lysis
[16]. In the previous studies, the alteration of the nucleic
acids in the tumorous blood samples could be detectable
by SERS,so the SERS signal assigned to the nucleic acids
in the serums can be employed as spectroscopic diagnostic
biomarker to screen and monitor the occurrence of par-
otid gland tumors [15, 16, 18]. The SERS peaks at around
933 cm−1, 1084 cm−1, 1094 cm−1, 1368–1373 cm−1 and
1441–1445 cm−1 are attributed to the relative molecular
structures in proteins. The higher intensities of these SERS
peaks assigned to proteins in the parotid gland tumor
serums demonstrated that there was an increase in the
amount of relative proteins in the parotid gland tumor
serums. Redistribution or translocation of plasma free
amino acids in cancer patients was reported in the pre-
vious literature and the level of plasma free amino acids
was related with the cancer type [32]. And the amount
of these amino acids in plasma would increase in some
cancers such as the breast cancer because these cancers
does not grow as fast as the metabolically active cancers
[32]. So these increased SERS peaks attributed to proteins
in the serums can be employed as a diagnostic indicator to
discriminate the parotid gland tumor serums from the
normal ones. Meanwhile, there are some other differences
existing in the SERS peaks of different parotid gland
tumors, which may be due to the tumors’ various metabo-
lisms and also can be considered as the diagnostic refer-
ences. But compared with the serum SERS spectra reported
in the other studies, some differences exist between the
spectra in this study and the ones reported in the lietratures
[29, 30]. These differences may result from the various
nano-particles, the different preparation of serum and
equipment parameters, and we could need a further re-
search to find an exact explanation.
Based on the SERS spectra of the serum samples, an
advanced algorithm is required to develop and establish an
powerful diagnostic system. Numerous algorithms have
been employed to analyze the Raman data such as principle
component analysis (PCA), discrimination function analysis
(DFA), partial least squares (PLS) and support vector ma-
chine (SVM). Compared with the other algorithms, SVM
have been applied more extensively in many studies such as
drug design, prediction of protein structure and diseases
diagnosis due to its remarkable generalization performance
[20, 35]. It is reported that SVM could classify and diagnose
the oral squamous cell carcinoma based on the Raman
spectra with the accuracy of approximate 98 % [25]. How-
ever, SVM is more powerful for the problem with small
sampling, nonlinear and high dimension, and the increase
of samples will waste more time and decrease the classifica-
tion performance [35, 36, 37]. In this study, in order to
Table 6 The parameters of the ‘Leave-one-patient’ classification
results of the spectra from the different parotid tumor samples
using SVM
Parameter PA vs WT PA vs MEC WT vs MEC
SP 57.4 % 69.5 % 78.9 %
SE 57.1 % 68.3 % 67.6 %
ACC 57.3 % 68.9 % 73.0 %
MCC 0.159 0.389 0.473
R 0.256 0.555 0.684
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reduce analytical errors, the process of classification by
using SVM consisted of two step as reported in the previ-
ous study [20]. When the leave-one-sample-out method
was applied for cross validation, the SERS spectra of tumor-
ous serums and normal serums were classified and diag-
nosed successfully with an average accuracy of 86 %. But
the accuracy of the classification carried out by the leave-
one-patient-out cross validation decreased, the reason
could be that only 4–6 independent spectra could not to-
tally represent the differences in the serum of one patient.
So in order to increase the diagnostic accuracy, the in-
ternal relation between the patient and spectrum should
be explored and established in the further study. However,
the classification results carried out by the two cross valid-
ation methods all manifested that WT was easier to be
misdiagnosed as normal than MEC and PA probably due
to the differences between benign and malignant tu-
mors. Among the types of parotid gland tumors
researched in this study, WT is benign tumor and MEC
is malignant tumor. Although PA is benign tumor, it is
considered as the critical tumor with the malignant degen-
eration potential [38]. So in the second step, MEC could
be easier to be discriminated from PA and WT due to the
diverse biological characters of the parotid gland tumors,
which was also in agreement with the result in the study
of Raman spectra of parotid gland tumor tissues [20]. But
Beleites et al. demonstrate that the test sample sizes are
necessary to achieve reasonable precision in the valid-
ation, too small sample size situation will completely
mask the learning curve [39]. So this result of our pre-
liminary study carried out by SVM could only demon-
strate the potential to diagnoses and classify the
different parotid gland tumors by SERS and SVM, and
a further study involving a great number of samples
should be needed. And the epidemiological characteris-
tics of various tumors resulted in the differences and unbal-
ances of the age and gender in the groups, which could
interfere the diagnostic results of this study, it is also
needed a large sample size experiment to give an explicit
explanation.
Conclusion
According to our knowledge, this is the first time to report
that the SERS combined with SVM could be employed
successfully to discriminate the serum samples of the
patients with parotid gland tumors from the ones of the
normal subjects and carry out a preoperative diagnosis of
the parotid gland tumors. The differences existing in the
SERS spectra of different samples manifested that the al-
terations of the biochemical metabolites in the serums
from the patients with parotid gland tumors and normal
control subjects. The serum SERS combined with SVM
algorithm may have a giant potential to apply in the pre-
operative diagnosis and screening of parotid gland tumors
if the further study could establish the relation between
the spectra and patients.
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